Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

ASTCT

Filed by SMITHBUCKLIN CORPORATION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$70,000.00
Expenses
Not reported
Client
ASTCT
Filing UUID
d27f5c41-2b83-43d4-bd9b-3840d88365f2
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Labor-HHS Appropriations Billing and Coding CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients Patient-Care Episode Financial Toxicity NIH Funding Cancer Moonshot H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025

Literal federal measure citations: H.R. 1509, S. 752, H.R. 2491, S. 1227, H.R. 5160

MMM · Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - Patient Care Episode - Financial Toxicity - Cancer Moonshot - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Literal federal measure citations: H.R. 1509, S. 752, H.R. 2491, S. 1227

MED · Medical/Disease Research/Clinical Labs

- Labor-HHS Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement - Cancer Moonshot - NIH Funding

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.